Arts

Books

Fashion & Beauty

Performing Arts

Food

Visual Arts

Design

Business

Entrepreneurship

Investing

Marketing

Careers

Management

Non-Profit

Comedy

Stand-Up

Comedy Interviews

Improv

Education

Self-Improvement

How To

Courses

Language Learning

Fiction

Comedy Fiction

Drama

Science Fiction

Government

Health & Fitness

Medicine

Alternative Health

Nutrition

Mental Health

Fitness

Sexuality

History

Kids & Family

Parenting

Stories for Kids

Education for Kids

Pets & Animals

Leisure

Video Games

Games

Automotive

Animation & Manga

Hobbies

Aviation

Home & Garden

Crafts

Music

Music Commentary

Music Interviews

Music History

News

Sports News

Entertainment News

News Commentary

Politics

Daily News

Business News

Tech News

Religion & Spirituality

Christianity

Spirituality

Religion

Judaism

Islam

Buddhism

Hinduism

Science

Social Sciences

Life Sciences

Natural Sciences

Nature

Chemistry

Mathematics

Earth Sciences

Physics

Astronomy

Society & Culture

Documentary

Relationships

Philosophy

Personal Journals

Places & Travel

Sports

Golf

Soccer

Wrestling

Basketball

Football

Fantasy Sports

Baseball

Wilderness

Running

Hockey

Rugby

Cricket

Volleyball

Tennis

Swimming

Technology

True Crime

TV & Film

Film Interviews

TV Reviews

After Shows

Film Reviews

Film History

Ciclo di catechesi sull'opera "Apparecchio alla morte" di sant'Alfonso M. de' Liguori, iniziato il 13 settembre 2024 Diventa un supporter di questo podcast: <a href="https://www.spreaker.com/podcast/apparecchio-alla-morte--6294993/support?utm_source=rss&utm_medium=rss&utm_campaign=rss">https://www.spreaker.com/podcast/apparecchio-alla-morte--6294993/support</a>.

Ciclo di catechesi sull'opera "Apparecchio alla morte" di sant'Alfonso M. de' Liguori, iniziato il 13 settembre 2024Diventa un supporter di questo podcast: https://www.spreaker.com/podcast/apparecchio-alla-morte--6294993/support.

Ciclo di catechesi sull'opera "Apparecchio alla morte" di sant'Alfonso M. de' Liguori, iniziato il 13 settembre 2024 Diventa un supporter di questo podcast: <a href="https://www.spreaker.com/podcast/apparecchio-alla-morte--6294993/support?utm_source=rss&amp;utm_medium=rss&amp;utm_campaign=rss" rel="noopener noreferrer">https://www.spreaker.com/podcast/apparecchio-alla-morte--6294993/support</a>.

Apparecchio alla morte

Algo de Magia es eso que vemos en todo lo que hacemos cuando empezamos a ver la vida conectados desde nuestro interior. ¡Hola! Soy Paa Vélez y acompáñame en este espacio, que como en la vida, no dejaremos de aprender y descubrir nuestra magia interior.

Algo de Magia

Las historias detrás de una conexión, el fabricante detrás de cada instrumento musical, la creación detrás de cada sonido.

En este podcast presentamos lo que empieza como una idea, pasa a ser un instrumento, y crea una industria exitosa, en este caso, la Argentina.

Una coproducción de TRIPEA y la CAFIM (Cámara Argentina de Fabricantes de Instrumentos Musicales)

Las historias detrás de una conexión, el fabricante detrás de cada instrumento musical, la creación detrás de cada sonido. En este podcast presentamos lo que empieza como una idea, pasa a ser un instrumento, y crea una industria exitosa, en este caso, la Argentina. Una coproducción de TRIPEA y la CAFIM (Cámara Argentina de Fabricantes de Instrumentos Musicales)

Fábrica de Sonidos

Acompaña a @Rocolitta a explorar todo el arte que es parte y hace posible que exista una industria musical. Conoce cómo se conectan la fotografía, la ilustración y más, con la música.

Una producción original de Tripea

Acompaña a @Rocolitta a explorar todo el arte que es parte y hace posible que exista una industria musical. Conoce cómo se conectan la fotografía, la ilustración y más, con la música. Una producción original de Tripea

El Sampler

La propiedad intelectual está por todos lados y muchas veces no la vemos, por eso Andreina Andrade (abogada especializada en propiedad intelectual) nos invita un cafecito para conocer historias de casos sobre PI en la cultura popular y nos da tips para no caer en los mismos errores con nuestras marcas. 

Producción Original de Tripea

La propiedad intelectual está por todos lados y muchas veces no la vemos, por eso Andreina Andrade (abogada especializada en propiedad intelectual) nos invita un cafecito para conocer historias de casos sobre PI en la cultura popular y nos da tips para no caer en los mismos errores con nuestras marcas. Producción Original de Tripea

Un cafecito de Propiedad Intelectual

ما أنت إن لم تكن أنت؟
!كل شئ يبدو بعيدًا باهتًا فظيعًا حين لا تكون أنت

.هنا أتحدث عني وعنك، كما أنا، لتكن أنت

ما أنت إن لم تكن أنت؟ !كل شئ يبدو بعيدًا باهتًا فظيعًا حين لا تكون أنت .هنا أتحدث عني وعنك، كما أنا، لتكن أنت

كن أنت | Bee you

Im Helden Podcast lassen wir Menschen zu Wort kommen, die ihr Leben in die eigenen Hände genommen haben.

Menschen, die sich trauen etwas Neues zu machen.
Menschen, die das Leben feiern.
Menschen die Mut haben ihrem Herzen zu folgen.

Lass Dich von verschiedenen Heldenreisen und Heldentaten inspirieren und starte Deine eigene Reise zum eigenen Heldenleben.
Yolo - Du Lebst vielleicht nur einmal, also mach Dir die Welt wie sie Dir gefällt.

Falls Du selbst eine inspirierende Heldenreise zu erzählen hast, dann bewirb Dich mit Deiner Geschichte auf https://helden.community für ein Interview.

Im Helden Podcast lassen wir Menschen zu Wort kommen, die ihr Leben in die eigenen Hände genommen haben. Menschen, die sich trauen etwas Neues zu machen. Menschen, die das Leben feiern. Menschen die Mut haben ihrem Herzen zu folgen. Lass Dich von verschiedenen Heldenreisen und Heldentaten inspirieren und starte Deine eigene Reise zum eigenen Heldenleben. Yolo - Du Lebst vielleicht nur einmal, also mach Dir die Welt wie sie Dir gefällt. Falls Du selbst eine inspirierende Heldenreise zu erzählen hast, dann bewirb Dich mit Deiner Geschichte auf https://helden.community für ein Interview.

Helden Podcast - Heldenreisen und Heldentaten

Hi wir sind Julia und Fynn und in unserem Podcast Millionaire Spirit nehmen wir Dich mit in den Alltag einer Unternehmerfamilie mit Millionen-Business. 

Gemeinsam gestalten wir Millionaire Spirit.

Hier geht es nicht nur um die Unternehmer-Themen wie Marketing, Manifestieren, Verkauf, Strategie, Mindset usw., sondern wir reden hier über Gott und die Welt.

Und Fynn am liebsten über Zigarren.

Vielleicht philosophieren wir auch mal übers Leben.
Oder reden über die Zeit, als wir noch nicht in einer Millionenvilla am Mittelmeer wohnten und völlig frei waren, sondern als wir noch in einer Doppelhaushälfte am Niederrhein lebten.
Oder darüber, was wir gemacht haben, diese Veränderung zu bewirken.
Oder über Wein.
Über Tierschutzkatzen.
Übers Reisen.
Über Spiritualität und das Manifestieren von großen Zielen.

Ach, einfach über alles.

Über unser Unternehmen Pro Charisma:

Gegründet 1997 von Julia Sobainsky, wird es heute durch sie und ihre Söhne Fynn Fenselau und Daniel Tuchscherer geleitet. 
Als Familienunternehmen beeinflussen sie die deutschsprachige Online-Coaching-Szene maßgeblich und haben im Laufe der letzten Jahre tausenden von Unternehmern zu Wohlstand und einem deutlich leichteren Business verholfen. 

MEHR VON UNS:
https://pro-charisma.clickfunnels.com/millionaire-spirit-beschreibung6wlxz3mf

Hi wir sind Julia und Fynn und in unserem Podcast Millionaire Spirit nehmen wir Dich mit in den Alltag einer Unternehmerfamilie mit Millionen-Business. Gemeinsam gestalten wir Millionaire Spirit. Hier geht es nicht nur um die Unternehmer-Themen wie Marketing, Manifestieren, Verkauf, Strategie, Mindset usw., sondern wir reden hier über Gott und die Welt. Und Fynn am liebsten über Zigarren. Vielleicht philosophieren wir auch mal übers Leben. Oder reden über die Zeit, als wir noch nicht in einer Millionenvilla am Mittelmeer wohnten und völlig frei waren, sondern als wir noch in einer Doppelhaushälfte am Niederrhein lebten. Oder darüber, was wir gemacht haben, diese Veränderung zu bewirken. Oder über Wein. Über Tierschutzkatzen. Übers Reisen. Über Spiritualität und das Manifestieren von großen Zielen. Ach, einfach über alles. Über unser Unternehmen Pro Charisma: Gegründet 1997 von Julia Sobainsky, wird es heute durch sie und ihre Söhne Fynn Fenselau und Daniel Tuchscherer geleitet. Als Familienunternehmen beeinflussen sie die deutschsprachige Online-Coaching-Szene maßgeblich und haben im Laufe der letzten Jahre tausenden von Unternehmern zu Wohlstand und einem deutlich leichteren Business verholfen. MEHR VON UNS: https://pro-charisma.clickfunnels.com/millionaire-spirit-beschreibung6wlxz3mf

MILLIONAIRE SPIRIT - Aus dem Alltag einer Unternehmerfamilie

Botafogo PodCast é um dos lançamentos da nova Botafogo TV, com objetivo de conhecer mais das personalidades que tem relação com o Glorioso.

Botafogo PodCast

European basketball, British perspective.

Long-time journalist and play-by-play commentator Niall Gray with a new podcast, featuring guests each episode.

European basketball, British perspective. Long-time journalist and play-by-play commentator Niall Gray with a new podcast, featuring guests each episode.

The Euro Step Brit Podcast

Vad kom först, hönan eller ägget? Det svarar vi på och den här podden handlar om allt som har med höns att göra. Högt och lågt, stort som smått. Vi är två hönsälskande personer, Per Forslund och Helena Abrahamsson som bestämde oss för att prata om höns i dina hörlurar. Häng med oss genom Sverige och till uppfödare och hönsälskare här och där. Allt från rashöns till blandraser, vi tar upp slakt, sjukdomar och allmänt småpratar om höns och livet med höns.<hr> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.

Vad kom först, hönan eller ägget? Det svarar vi på och den här podden handlar om allt som har med höns att göra. Högt och lågt, stort som smått. Vi är två hönsälskande personer, Per Forslund och Helena Abrahamsson som bestämde oss för att prata om höns i dina hörlurar. Häng med oss genom Sverige och till uppfödare och hönsälskare här och där. Allt från rashöns till blandraser, vi tar upp slakt, sjukdomar och allmänt småpratar om höns och livet med höns. Hosted on Acast. See acast.com/privacy for more information.

Vad kom först, hönan eller ägget? Det svarar vi på och den här podden handlar om allt som har med höns att göra. Högt och lågt, stort som smått. Vi är två hönsälskande personer, Per Forslund och Helena Abrahamsson som bestämde oss för att prata om höns i dina hörlurar. Häng med oss genom Sverige och till uppfödare och hönsälskare här och där. Allt från rashöns till blandraser, vi tar upp slakt, sjukdomar och allmänt småpratar om höns och livet med höns. Hosted on Acast. See <a href="https://acast.com/privacy" rel="noopener noreferrer">acast.com/privacy</a> for more information.

Hönspodden

It may be lurking in the dark or on a broad daylight. One can be an innocent, accidental victim, mistaken identity or a deliberate target. But the result is the same. The rules of the crime world is still primitive -- prey and predator, where brutal, cold means of inflicting attacks on unsuspecting targets. Pathaka Loka or the Criminal World explores various crimes in Karnataka, that have shattered many dreams, destroyed many lives before being caught up by the law. Still, one can not say that justice was rendered to the victims as many cases end up with acquittal by the Courts. Pathaka Loka digs into the various angles of infamous crime incidents of Karnataka, that shook the people living in comfort zones.

Paathaka Loka - A Kannada True Crime Podcast

The podcast where we talk about all the business tactics, personal resilience, and fears around starting up your direct primary care practice.

Dream DPC

映像ディレクターのべびと、デザイナーのひろぽんがお送りするポッドキャスト。毎週月曜日あさ5時からお届けする、アラフォーゲイふたりのまるで寝言のような雑談配信です。


毎週月曜日 あさ5時から配信！！


📩おたよりはこちらへ。番組へのご意見、ご感想、寝言などお待ちしています。
https://forms.gle/x6rMVukjJYgSXBa88


🔔各種SNSはこちら。
https://lit.link/BebiponNegoto

映像ディレクターのべびと、デザイナーのひろぽんがお送りするポッドキャスト。毎週月曜日あさ5時からお届けする、アラフォーゲイふたりのまるで寝言のような雑談配信です。 毎週月曜日 あさ5時から配信！！ 📩おたよりはこちらへ。番組へのご意見、ご感想、寝言などお待ちしています。 https://forms.gle/x6rMVukjJYgSXBa88 🔔各種SNSはこちら。 https://lit.link/BebiponNegoto

べびぽんの『起きてたって、寝言。』

Med udgangspunkt i eksempler fra medier og politik bliver du i ”Økonomiske principper” introduceret til centrale økonomiske emner og begreber samt får en bred, simpel indføring i grundlæggende økonomisk tankegang.

Du får bl.a. et indblik i basal økonomisk teori for økonomiske aktørers adfærd, markedsmekanismens funktionsmåde, teori om markeder og velfærd, effekter af beskatning på markedets funktionsmåde, markedsimperfektioner i form af såkaldt offentlige goder og eksternaliteter, betydningen af forskellige konkurrenceformer, fordele og ulemper ved et frit marked, reguleringspolitik samt effekter af international handel.
Podcastens titel er taget fra det helt grundlæggende fag på økonomistudiet på Københavns Universitet (cand.polit).

CLAUS & JONAS
Claus Galbo-Jørgensen er cheføkonom i advokatfirmaet Bech-Bruun og er desuden ekstern lektor i økonomi på Københavns Universitet.

https://twitter.com/clausbjorn
https://www.linkedin.com/in/clausbjorn/
https://www.bechbruun.com/da/mennesker/cgj

Jonas Herby er specialkonsulent i tænketanken CEPOS og podcastvært på Regelstaten.

https://twitter.com/JonasHerby
https://www.facebook.com/jonasherby
herby@cepos.dk

SEND EN MAIL!
Send os en mail med kommentarer, ris og ros på principperne@gmail.com

Med udgangspunkt i eksempler fra medier og politik bliver du i ”Økonomiske principper” introduceret til centrale økonomiske emner og begreber samt får en bred, simpel indføring i grundlæggende økonomisk tankegang. Du får bl.a. et indblik i basal økonomisk teori for økonomiske aktørers adfærd, markedsmekanismens funktionsmåde, teori om markeder og velfærd, effekter af beskatning på markedets funktionsmåde, markedsimperfektioner i form af såkaldt offentlige goder og eksternaliteter, betydningen af forskellige konkurrenceformer, fordele og ulemper ved et frit marked, reguleringspolitik samt effekter af international handel. Podcastens titel er taget fra det helt grundlæggende fag på økonomistudiet på Københavns Universitet (cand.polit). CLAUS & JONAS Claus Galbo-Jørgensen er cheføkonom i advokatfirmaet Bech-Bruun og er desuden ekstern lektor i økonomi på Københavns Universitet. https://twitter.com/clausbjorn https://www.linkedin.com/in/clausbjorn/ https://www.bechbruun.com/da/mennesker/cgj Jonas Herby er specialkonsulent i tænketanken CEPOS og podcastvært på Regelstaten. https://twitter.com/JonasHerby https://www.facebook.com/jonasherby herby@cepos.dk SEND EN MAIL! Send os en mail med kommentarer, ris og ros på principperne@gmail.com

Med udgangspunkt i eksempler fra medier og politik bliver du i ”Økonomiske principper” introduceret til centrale økonomiske emner og begreber samt får en bred, simpel indføring i grundlæggende økonomisk tankegang.

Du får bl.a. et indblik i basal økonomisk teori for økonomiske aktørers adfærd, markedsmekanismens funktionsmåde, teori om markeder og velfærd, effekter af beskatning på markedets funktionsmåde, markedsimperfektioner i form af såkaldt offentlige goder og eksternaliteter, betydningen af forskellige konkurrenceformer, fordele og ulemper ved et frit marked, reguleringspolitik samt effekter af international handel.
Podcastens titel er taget fra det helt grundlæggende fag på økonomistudiet på Københavns Universitet (cand.polit).

CLAUS &amp; JONAS
Claus Galbo-Jørgensen er cheføkonom i advokatfirmaet Bech-Bruun og er desuden ekstern lektor i økonomi på Københavns Universitet.

https://twitter.com/clausbjorn
https://www.linkedin.com/in/clausbjorn/
https://www.bechbruun.com/da/mennesker/cgj

Jonas Herby er specialkonsulent i tænketanken CEPOS og podcastvært på Regelstaten.

https://twitter.com/JonasHerby
https://www.facebook.com/jonasherby
herby@cepos.dk

SEND EN MAIL!
Send os en mail med kommentarer, ris og ros på principperne@gmail.com

Økonomiske principper

The world is about to change.
Warriors, assassins, fair maidens, court officials and even the emperor and heavenly immortals are nothing but pawns on a giant chessboard.
Xu Fengnian, a playboy of national notoriety and heir to the empire’s second most powerful man, finds himself embroiled in the depth of an unbeatable game…
Immerse yourself in a world brimming with heroism and follow a young man’s odyssey in this audio drama series “The Sword Strider Saga.”

The world is about to change. Warriors, assassins, fair maidens, court officials and even the emperor and heavenly immortals are nothing but pawns on a giant chessboard. Xu Fengnian, a playboy of national notoriety and heir to the empire’s second most powerful man, finds himself embroiled in the depth of an unbeatable game… Immerse yourself in a world brimming with heroism and follow a young man’s odyssey in this audio drama series “The Sword Strider Saga.”

The world is about to change.
Warriors, assassins, fair maidens, court officials and even the emperor and heavenly immortals are nothing but pawns on a giant chessboard.
Xu Fengnian, a playboy of national notoriety and heir to the empire’s second most powerful man, finds himself embroiled in the depth of an unbeatable game…
Immerse yourself in a world brimming with heroism and follow a young man’s odyssey in this audio drama series “The Sword Strider Saga.”

The Sword Strider Saga

Un podcast rivolto a chi desidera capire meglio il proprio cane e a chi vuole adottarne uno con consigli pratici e semplici di Andrea Bonfrate, educatore cinofilo.
Se vuoi vedere video, foto, conoscere i cani di cui racconto e ricevere informazioni sulla cinofilia iscriviti al canale whatsapp Cani, capirli per educarli.
Hai domande che vorresti farmi? Vorresti lavorare con me? Scrivimi!
bonfrateandrea@gmail.com
---
Questo podcast fa parte di Hypercast Network — 📧 Per proposte commerciali scrivi a: r.verrengia@hypercast.studio

Un podcast rivolto a chi desidera capire meglio il proprio cane e a chi vuole adottarne uno con consigli pratici e semplici di Andrea Bonfrate, educatore cinofilo. Se vuoi vedere video, foto, conoscere i cani di cui racconto e ricevere informazioni sulla cinofilia iscriviti al canale whatsapp Cani, capirli per educarli. Hai domande che vorresti farmi? Vorresti lavorare con me? Scrivimi! bonfrateandrea@gmail.com --- Questo podcast fa parte di Hypercast Network — 📧 Per proposte commerciali scrivi a: r.verrengia@hypercast.studio

Cani, capirli per educarli

A collection of famous and lesser known stories for children of all ages. Great for car journeys or bedtimes.&nbsp;

A collection of famous and lesser known stories for children of all ages. Great for car journeys or bedtimes. 

Sami's Bedtime Stories

🕒 Prions ensemble chaque soir à 20h ✨ Prions et sanctifions notre temps avec la puissance prière de La Liturgie des Heures ! 📜 Une prière ancestrale déjà vécue quotidiennement par le peuple d'Israël dès les premiers siècles, et dont nous sommes les héritiers par les apôtres 📖 Colossien 3, 16 et Ephésien 5,19. 🎵 Cette liturgie est basée sur la prière des psaumes, et accompagnée de passages de la Bible, d'hymnes, de réponds, etc. 💁🏾‍♂️ Lue et interprétée par Constant SESSOU Bonne prière 🙏

🕒 Prions ensemble chaque soir à 20h ✨ Prions et sanctifions notre temps avec la puissance prière de La Liturgie des Heures ! 📜 Une prière ancestrale déjà vécue quotidiennement par le peuple d'Israël dès les premiers siècles, et dont nous sommes les héritiers par les apôtres 📖 Colossien 3, 16 et Ephésien 5,19. 🎵 Cette liturgie est basée sur la prière des psaumes, et accompagnée de passages de la Bible, d'hymnes, de réponds, etc. 💁🏾‍♂️ Lue et interprétée par Constant SESSOU Bonne prière 🙏

🕒 Prions ensemble chaque soir à 20h ✨ Prions et sanctifions notre temps avec la puissance prière de La Liturgie des Heures ! 📜 Une prière ancestrale déjà vécue quotidiennement par le peuple d'Israël dès les premiers siècles, et dont nous sommes les héritiers par les apôtres 📖 Colossien 3, 16 et Ephésien 5,19. 🎵 Cette liturgie est basée sur la prière des psaumes, et accompagnée de passages de la Bible, d'hymnes, de réponds, etc. 💁🏾‍♂️ Lue et interprétée par Constant SESSOU Bonne prière 🙏

La Liturgie des Heures

Vous pensez que l’organisation, c’est juste ranger ? Détrompez-vous ! Je suis Sarah, consultante en organisation et aménagement d'espaces, et je vous montre comment un espace de vie ou de travail optimisé peut booster votre productivité, réduire les coûts liés à la désorganisation et vous simplifier la vie. 

Conseils concrets, astuces et couleurs, méthodes efficaces… Transformez vos espaces et gagnez du temps au quotidien.

Vous pensez que l’organisation, c’est juste ranger ? Détrompez-vous ! Je suis Sarah, consultante en organisation et aménagement d'espaces, et je vous montre comment un espace de vie ou de travail optimisé peut booster votre productivité, réduire les coûts liés à la désorganisation et vous simplifier la vie. Conseils concrets, astuces et couleurs, méthodes efficaces… Transformez vos espaces et gagnez du temps au quotidien.

Parlons organisation, avec Sarah

Hej och välkommen till Ehandelsnack! 

I den här podcasten kommer vi att diskutera allt som rör e-handel. Vi vill ta upp aktuella trender, nya teknologier och många andra ämnen. 

Vi kommer också bjuda in spännande gäster som delar med sig av sina erfarenheter och insikter från e-handelsbranschen. Vi tror att det här kommer att vara en värdefull resurs för alla som är intresserade av e-handel, från små företagare till etablerade e-handelsjättar. Så häng med oss när vi utforskar den spännande världen av e-handel i Ehandelsnack.

Hej och välkommen till Ehandelsnack! I den här podcasten kommer vi att diskutera allt som rör e-handel. Vi vill ta upp aktuella trender, nya teknologier och många andra ämnen. Vi kommer också bjuda in spännande gäster som delar med sig av sina erfarenheter och insikter från e-handelsbranschen. Vi tror att det här kommer att vara en värdefull resurs för alla som är intresserade av e-handel, från små företagare till etablerade e-handelsjättar. Så häng med oss när vi utforskar den spännande världen av e-handel i Ehandelsnack.

Ehandelsnack

Đây là nơi lưu giữ các tác phẩm của nhà văn Hồ Biểu Chánh được Kẻ Trộm Hương thê rhiejen qua một hình thức mới, lôi cuốn hơn, chứ không đơn thuần là sách nói!

Nếu yêu thích Podcast này, xin hãy đánh giá 5 sao hoặc dành cho Kẻ Trộm Hương một tách cà phê nhé: https://www.buymeacoffee.com/ketromhuong.

Đây là nơi lưu giữ các tác phẩm của nhà văn Hồ Biểu Chánh được Kẻ Trộm Hương thê rhiejen qua một hình thức mới, lôi cuốn hơn, chứ không đơn thuần là sách nói! Nếu yêu thích Podcast này, xin hãy đánh giá 5 sao hoặc dành cho Kẻ Trộm Hương một tách cà phê nhé: https://www.buymeacoffee.com/ketromhuong.

Hồ Biểu Chánh - Tiểu Thuyết Và Truyện Ngắn

عيش

היי אנחנו קובי והדר זהבי
קובי, יזם, משקיע נדל”ן, מלווה משקיעים ומטפל ברפואה סינית והדר משקיעת נדל”ן, מלווה משקיעים ואחות מוסמכת

לפני כמה שנים הבנו שהעולם משתנה תדיר, שדבר אינו דומה למה שהיה. שוק העבודה משתנה, החיים נעשים יקרים יותר ויותר והתחושה והרצון לשאוף לביטחון ועצמאות כלכלית החלה לבעור בנו, הבנו שאנו חייבים לדאוג לתא המשפחתי שלנו ואין אף אחד שיעשה זאת מלבדנו. מה שהוביל אותנו לצאת למסע שבו למדנו את מה שלא דאגו ללמד אותנו בבית הספר או בבית- השכלה פיננסית והתנהלות כלכלית נכונה.

מתוך תחושה של אחריות אישית לעתידנו הכלכלי, התחלנו ללמוד ולחקור את האפשרויות בתחום הכסף וההשקעות. גילינו את עולם הנדל”ן ואת ההזדמנויות הטמונות בו.

בתחילה ביצענו השקעות עבורנו ועבור משפחה וחברים, מה שהוביל אותנו להקים את ”השקעה נכונה”. כיום אנו מלווים משקיעים לאורך כל תהליך ההשקעה בנדל”ן מתוך מקום של ידע ומתן תחושת ביטחון וודאות בתהליך ההשקעה.
----------------------------------
אין לראות בנאמר בקבוצה המלצה או יעוץ.
כל הנאמר בפודקאסט,פוסטים,תגובות,לייב, מאמרים וכו’ אינו המלצה או תחליף ליעוץ. המידע בקבוצה עשוי להיות חסר/שגוי/לא עדכני/לא מותאם לצרכים המתאימים והאישיים של כל אדם. חובה להתייעץ באיש מקצוע טרם יעשה בו שימוש.
בעלי הקבוצה לא ישאו באחריות לכל נזק שנגרם כתוצאה ישירה או עקיפה משימוש בתכנים.

היי אנחנו קובי והדר זהבי קובי, יזם, משקיע נדל”ן, מלווה משקיעים ומטפל ברפואה סינית והדר משקיעת נדל”ן, מלווה משקיעים ואחות מוסמכת לפני כמה שנים הבנו שהעולם משתנה תדיר, שדבר אינו דומה למה שהיה. שוק העבודה משתנה, החיים נעשים יקרים יותר ויותר והתחושה והרצון לשאוף לביטחון ועצמאות כלכלית החלה לבעור בנו, הבנו שאנו חייבים לדאוג לתא המשפחתי שלנו ואין אף אחד שיעשה זאת מלבדנו. מה שהוביל אותנו לצאת למסע שבו למדנו את מה שלא דאגו ללמד אותנו בבית הספר או בבית- השכלה פיננסית והתנהלות כלכלית נכונה. מתוך תחושה של אחריות אישית לעתידנו הכלכלי, התחלנו ללמוד ולחקור את האפשרויות בתחום הכסף וההשקעות. גילינו את עולם הנדל”ן ואת ההזדמנויות הטמונות בו. בתחילה ביצענו השקעות עבורנו ועבור משפחה וחברים, מה שהוביל אותנו להקים את ”השקעה נכונה”. כיום אנו מלווים משקיעים לאורך כל תהליך ההשקעה בנדל”ן מתוך מקום של ידע ומתן תחושת ביטחון וודאות בתהליך ההשקעה. ---------------------------------- אין לראות בנאמר בקבוצה המלצה או יעוץ. כל הנאמר בפודקאסט,פוסטים,תגובות,לייב, מאמרים וכו’ אינו המלצה או תחליף ליעוץ. המידע בקבוצה עשוי להיות חסר/שגוי/לא עדכני/לא מותאם לצרכים המתאימים והאישיים של כל אדם. חובה להתייעץ באיש מקצוע טרם יעשה בו שימוש. בעלי הקבוצה לא ישאו באחריות לכל נזק שנגרם כתוצאה ישירה או עקיפה משימוש בתכנים.

היי אנחנו קובי והדר זהבי
קובי, יזם, משקיע נדל”ן, מלווה משקיעים ומטפל ברפואה סינית והדר משקיעת נדל”ן, מלווה משקיעים ואחות מוסמכת

לפני כמה שנים הבנו שהעולם משתנה תדיר, שדבר אינו דומה למה שהיה. שוק העבודה משתנה, החיים נעשים יקרים יותר ויותר והתחושה והרצון לשאוף לביטחון ועצמאות כלכלית החלה לבעור בנו, הבנו שאנו חייבים לדאוג לתא המשפחתי שלנו ואין אף אחד שיעשה זאת מלבדנו. מה שהוביל אותנו לצאת למסע שבו למדנו את מה שלא דאגו ללמד אותנו בבית הספר או בבית- השכלה פיננסית והתנהלות כלכלית נכונה.

מתוך תחושה של אחריות אישית לעתידנו הכלכלי, התחלנו ללמוד ולחקור את האפשרויות בתחום הכסף וההשקעות. גילינו את עולם הנדל”ן ואת ההזדמנויות הטמונות בו.

בתחילה ביצענו השקעות עבורנו ועבור משפחה וחברים, מה שהוביל אותנו להקים את ”השקעה נכונה”. כיום אנו מלווים משקיעים לאורך כל תהליך ההשקעה בנדל”ן מתוך מקום של ידע ומתן תחושת ביטחון וודאות בתהליך ההשקעה.
----------------------------------
אין לראות בנאמר בקבוצה המלצה או יעוץ.
כל הנאמר בפודקאסט,פוסטים,תגובות,לייב, מאמרים וכו’ אינו המלצה או תחליף ליעוץ. המידע בקבוצה עשוי להיות חסר/שגוי/לא עדכני/לא מותאם לצרכים המתאימים והאישיים של כל אדם. חובה להתייעץ באיש מקצוע טרם יעשה בו שימוש.
בעלי הקבוצה לא ישאו באחריות לכל נזק שנגרם כתוצאה ישירה או עקיפה&nbsp;משימוש&nbsp;בתכנים.

נדלן משפחתי

先週観た映画と今週観たい映画についてゆるく雑談していくプログラムです。

cinema de akubi

As histórias mais lindas cheias de detalhes e sons que te farão dormir em minutos!
Eu sou o gabs e sou a sua nova companhia de todas as noites ❤️

Apoie o Podcast: https://apoia.se/historiaspraadultodormir

Tem dois episódios novos por semana! O soninho vai começar :)

Feche os olhos, aperte o play e durma com o gabs :)

📧 Contato: gabrielbernardu@heartbitage.com

📲 Me acompanhe no Instagram → @historiaspraadultodormir ou @gabrielbernardu

#históriasparadormir #podcastparadormir #relaxar

As histórias mais lindas cheias de detalhes e sons que te farão dormir em minutos! Eu sou o gabs e sou a sua nova companhia de todas as noites ❤️ Apoie o Podcast: https://apoia.se/historiaspraadultodormir Tem dois episódios novos por semana! O soninho vai começar :) Feche os olhos, aperte o play e durma com o gabs :) 📧 Contato: gabrielbernardu@heartbitage.com 📲 Me acompanhe no Instagram → @historiaspraadultodormir ou @gabrielbernardu #históriasparadormir #podcastparadormir #relaxar

Histórias pra adulto dormir

大分県日田市の青年農業者グループ『通称:日田郡連』のメンバーがお届けする農系ポッドキャスト番組です。
　
農業のこと、日田のこと、自分たちのことなど色々話していきたいと思います。
　
配信日は、基本毎月1日のAM6:00です。
　
X(旧twitter)、Instagramで配信のお知らせなどを発信しています。
・X → https://twitter.com/hitagunren
・ Instagram → https://www.instagram.com/hita_agriculture_radio

-----番組の感想、ふつおた、ご質問などこちらのメールフォーム、またはメールアドレスからお気軽にお寄せください！-----
・メールフォーム → https://forms.gle/PhWqEbh8cWQbog7N6
・メールアドレス → hitanouradio@gmail.com

　
Xでポストする時は、#ひた農らじお　をつけてお願いします！Instagramでもコメントお待ちしています！

※日田郡連とは、大分県日田市で活動する地区4Hクラブです。

大分県日田市の青年農業者グループ『通称:日田郡連』のメンバーがお届けする農系ポッドキャスト番組です。 農業のこと、日田のこと、自分たちのことなど色々話していきたいと思います。 配信日は、基本毎月1日のAM6:00です。 X(旧twitter)、Instagramで配信のお知らせなどを発信しています。 ・X → https://twitter.com/hitagunren ・ Instagram → https://www.instagram.com/hita_agriculture_radio -----番組の感想、ふつおた、ご質問などこちらのメールフォーム、またはメールアドレスからお気軽にお寄せください！----- ・メールフォーム → https://forms.gle/PhWqEbh8cWQbog7N6 ・メールアドレス → hitanouradio@gmail.com Xでポストする時は、#ひた農らじお をつけてお願いします！Instagramでもコメントお待ちしています！ ※日田郡連とは、大分県日田市で活動する地区4Hクラブです。

ひた農らじお

Reviews, interviews, and music news. All here in one place.

The Review Show

いいと思っていること、考えていることをきりん(@sota1235)とだて(@d_date)が言語化したいPodcastです
テーマは技術や仕事、なんでも

ポッドキャスト文字起こしサービスLISTENはこちら
https://listen.style/p/1n0cyluy?KhZfJEkl

いいと思っていること、考えていることをきりん(@sota1235)とだて(@d_date)が言語化したいPodcastです テーマは技術や仕事、なんでも ポッドキャスト文字起こしサービスLISTENはこちら https://listen.style/p/1n0cyluy?KhZfJEkl

言語化.fm

MDMA (3,4-methylenedioxymethamphetamine), known commonly as Ecstasy or Molly, has transitioned from a popular recreational drug to a promising therapeutic tool. The unique psychoactive properties of MDMA, which enhance empathy and reduce fear, have made it a powerful aid in psychotherapy, particularly for treating severe psychological conditions like PTSD. This article delves into the historical context, mechanism of action, therapeutic applications, clinical trials, safety considerations, and future prospects of MDMA in therapeutic settings. MDMA has a fascinating history that spans over a century. It was first synthesized by the German pharmaceutical company Merck in 1912 as part of their research into blood-clotting medications. However, the psychoactive properties of MDMA remained unknown for decades. It wasn't until the 1970s that American chemist Alexander Shulgin re-synthesized MDMA in his lab. Shulgin, known for his pioneering work in psychedelic chemistry, recognized the unique effects of MDMA on the human psyche. Shulgin shared his findings with psychotherapist Leo Zeff, who saw the potential of MDMA as a therapeutic aid. Zeff introduced MDMA to the psychotherapy community, where it quickly gained popularity as a tool for facilitating emotional breakthroughs and enhancing the therapeutic alliance. Throughout the late 1970s and early 1980s, MDMA was used by a network of therapists who believed in its ability to catalyze healing. However, MDMA's rising popularity extended beyond therapeutic circles. It became a sought-after recreational drug, particularly in the rave and club scene. The increasing non-medical use of MDMA led to concerns about its potential for abuse and neurotoxicity. In 1985, the U.S. Drug Enforcement Administration (DEA) stepped in and classified MDMA as a Schedule I controlled substance. This classification placed severe restrictions on the legal use of MDMA, effectively halting its use in therapy and limiting research into its potential benefits. Despite the legal obstacles, a dedicated group of researchers and advocates continued to explore the therapeutic potential of MDMA. Organizations like the Multidisciplinary Association for Psychedelic Studies (MAPS) played a crucial role in advancing MDMA research, conducting clinical trials, and advocating for policy changes to facilitate its medical use. To understand how MDMA exerts its therapeutic effects, it's essential to examine its mechanism of action in the brain. MDMA primarily acts on three key neurotransmitter systems: serotonin, dopamine, and norepinephrine. When MDMA enters the brain, it causes a significant release of these neurotransmitters, leading to a cascade of psychological and physiological effects. Serotonin is perhaps the most important neurotransmitter involved in MDMA's action. MDMA causes a massive surge in serotonin levels, which is responsible for the drug's mood-elevating and prosocial effects. This increase in serotonin leads to feelings of euphoria, emotional warmth, and increased empathy. It allows individuals to connect with their emotions and with others in a profound way, which can be particularly beneficial in a therapeutic context. Dopamine, often associated with reward and motivation, is also affected by MDMA. The release of dopamine contributes to the pleasurable and energizing effects of the drug. It can enhance focus and engagement during therapy sessions, helping patients stay present and committed to the therapeutic process. Norepinephrine, a neurotransmitter involved in the body's stress response, is also increased by MDMA. This can lead to some of the physical effects of the drug, such as increased heart rate and blood pressure. However, the release of norepinephrine also plays a role in the emotional impact of MDMA. It can heighten emotional arousal and help individuals access and process difficult emotions. In addition to its effects on these neurotransmitters, MDMA has been shown to increase the release of oxytocin, often referred to as the "love hormone." Oxytocin is involved in social bonding, trust, and emotional regulation. The surge of oxytocin induced by MDMA can create a profound sense of connection and trust between the patient and therapist, fostering a strong therapeutic alliance. The combination of these neurochemical effects creates a unique psychological state characterized by reduced fear and defensiveness, increased empathy and emotional openness, and a heightened capacity for introspection and self-reflection. This state is particularly conducive to therapeutic work, allowing patients to access and process traumatic memories, emotions, and beliefs in a way that may not be possible under normal circumstances. It's important to note that the therapeutic effects of MDMA are not solely due to its pharmacological action. The drug is used as part of a carefully designed therapeutic protocol that includes preparatory sessions, MDMA-assisted sessions, and integrative follow-up sessions. The supportive and safe environment provided by trained therapists is crucial for maximizing the therapeutic potential of MDMA and minimizing the risks associated with its use. The therapeutic applications of MDMA are diverse and far-reaching, with the potential to address a range of mental health conditions. The most well-established and researched application of MDMA is in the treatment of post-traumatic stress disorder (PTSD). PTSD is a debilitating condition that can develop after exposure to a traumatic event, such as combat, sexual assault, or natural disasters. It is characterized by symptoms like intrusive memories, avoidance of trauma-related stimuli, negative alterations in cognition and mood, and hyperarousal. Traditional treatments for PTSD, such as cognitive-behavioral therapy and medication, have limitations and are not effective for everyone. MDMA-assisted psychotherapy has emerged as a promising alternative for individuals with PTSD, particularly those who have not responded to conventional treatments. The unique properties of MDMA, such as reducing fear and increasing empathy, make it well-suited for treating the core symptoms of PTSD. During MDMA-assisted therapy sessions, patients are able to revisit and process traumatic memories in a safe and supportive environment. The drug reduces the fear and emotional numbing associated with these memories, allowing patients to engage with them in a more constructive way. They can access and express emotions that may have been suppressed or avoided, leading to a cathartic release and a new perspective on their experiences. The Multidisciplinary Association for Psychedelic Studies (MAPS) has been at the forefront of research on MDMA-assisted therapy for PTSD. Their clinical trials have yielded impressive results, with a significant proportion of participants experiencing long-lasting improvements in their symptoms. In fact, the results have been so promising that the FDA has granted MDMA-assisted therapy a Breakthrough Therapy designation for PTSD, accelerating its path to approval. A recent article in The New York Times highlighted the anticipation surrounding the FDA's potential approval of MDMA-assisted therapy for PTSD. The article emphasized the transformative potential of this treatment, which could provide relief for the millions of individuals suffering from PTSD worldwide. It also underscored the importance of continued research and responsible use of MDMA in therapeutic settings. While PTSD is currently the primary focus of MDMA therapy research, there is growing interest in exploring its potential for other mental health conditions. Preliminary studies suggest that MDMA could be beneficial for treating depression, anxiety, and social anxiety in autistic adults. Depression, characterized by persistent low mood, loss of interest, and feelings of hopelessness, is a widespread and debilitating mental health condition. Current treatments, such as antidepressant medications and psychotherapy, are not always effective, leaving many individuals struggling with ongoing symptoms. MDMA's ability to promote emotional openness, self-compassion, and insight could make it a valuable tool in the treatment of depression. Similarly, MDMA's prosocial effects and reduction of fear could be particularly useful for individuals with anxiety disorders, including social anxiety disorder. By reducing the emotional barriers that prevent individuals from engaging in social situations, MDMA could facilitate exposure therapy and help individuals develop more adaptive coping strategies. Autism spectrum disorder (ASD) is another area where MDMA therapy shows promise. Many individuals with ASD struggle with social interactions and communication, which can lead to anxiety and isolation. MDMA's ability to enhance empathy and reduce social fears could help autistic adults navigate social situations more effectively and form meaningful connections with others. As research continues to expand, it's likely that new therapeutic applications of MDMA will emerge. The unique properties of this drug, combined with the supportive environment of psychotherapy, hold significant potential for addressing a range of mental health challenges. The resurgence of interest in MDMA as a therapeutic tool has been driven by a growing body of clinical research. In recent years, several landmark clinical trials have provided compelling evidence for the efficacy and safety of MDMA-assisted therapy, particularly for the treatment of PTSD. The most notable clinical trials have been conducted by the Multidisciplinary Association for Psychedelic Studies (MAPS), a non-profit research and educational organization dedicated to the development of medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics. MAPS has been at the forefront of MDMA research for over three decades, working tirelessly to advance the scientific understanding and clini

MDMA (3,4-methylenedioxymethamphetamine), known commonly as Ecstasy or Molly, has transitioned from a popular recreational drug to a promising therapeutic tool. The unique psychoactive properties of MDMA, which enhance empathy and reduce fear, have made it a powerful aid in psychotherapy, particularly for treating severe psychological conditions like PTSD. This article delves into the historical context, mechanism of action, therapeutic applications, clinical trials, safety considerations, and future prospects of MDMA in therapeutic settings. MDMA has a fascinating history that spans over a century. It was first synthesized by the German pharmaceutical company Merck in 1912 as part of their research into blood-clotting medications. However, the psychoactive properties of MDMA remained unknown for decades. It wasn't until the 1970s that American chemist Alexander Shulgin re-synthesized MDMA in his lab. Shulgin, known for his pioneering work in psychedelic chemistry, recognized the unique effects of MDMA on the human psyche. Shulgin shared his findings with psychotherapist Leo Zeff, who saw the potential of MDMA as a therapeutic aid. Zeff introduced MDMA to the psychotherapy community, where it quickly gained popularity as a tool for facilitating emotional breakthroughs and enhancing the therapeutic alliance. Throughout the late 1970s and early 1980s, MDMA was used by a network of therapists who believed in its ability to catalyze healing. However, MDMA's rising popularity extended beyond therapeutic circles. It became a sought-after recreational drug, particularly in the rave and club scene. The increasing non-medical use of MDMA led to concerns about its potential for abuse and neurotoxicity. In 1985, the U.S. Drug Enforcement Administration (DEA) stepped in and classified MDMA as a Schedule I controlled substance. This classification placed severe restrictions on the legal use of MDMA, effectively halting its use in therapy and limiting research into its potential benefits. Despite the legal obstacles, a dedicated group of researchers and advocates continued to explore the therapeutic potential of MDMA. Organizations like the Multidisciplinary Association for Psychedelic Studies (MAPS) played a crucial role in advancing MDMA research, conducting clinical trials, and advocating for policy changes to facilitate its medical use. To understand how MDMA exerts its therapeutic effects, it's essential to examine its mechanism of action in the brain. MDMA primarily acts on three key neurotransmitter systems: serotonin, dopamine, and norepinephrine. When MDMA enters the brain, it causes a significant release of these neurotransmitters, leading to a cascade of psychological and physiological effects. Serotonin is perhaps the most important neurotransmitter involved in MDMA's action. MDMA causes a massive surge in serotonin levels, which is responsible for the drug's mood-elevating and prosocial effects. This increase in serotonin leads to feelings of euphoria, emotional warmth, and increased empathy. It allows individuals to connect with their emotions and with others in a profound way, which can be particularly beneficial in a therapeutic context. Dopamine, often associated with reward and motivation, is also affected by MDMA. The release of dopamine contributes to the pleasurable and energizing effects of the drug. It can enhance focus and engagement during therapy sessions, helping patients stay present and committed to the therapeutic process. Norepinephrine, a neurotransmitter involved in the body's stress response, is also increased by MDMA. This can lead to some of the physical effects of the drug, such as increased heart rate and blood pressure. However, the release of norepinephrine also plays a role in the emotional impact of MDMA. It can heighten emotional arousal and help individuals access and process difficult emotions. In addition to its effects on these neurotransmitters, MDMA has been shown to increase the release of oxytocin, often referred to as the "love hormone." Oxytocin is involved in social bonding, trust, and emotional regulation. The surge of oxytocin induced by MDMA can create a profound sense of connection and trust between the patient and therapist, fostering a strong therapeutic alliance. The combination of these neurochemical effects creates a unique psychological state characterized by reduced fear and defensiveness, increased empathy and emotional openness, and a heightened capacity for introspection and self-reflection. This state is particularly conducive to therapeutic work, allowing patients to access and process traumatic memories, emotions, and beliefs in a way that may not be possible under normal circumstances. It's important to note that the therapeutic effects of MDMA are not solely due to its pharmacological action. The drug is used as part of a carefully designed therapeutic protocol that includes preparatory sessions, MDMA-assisted sessions, and integrative follow-up sessions. The supportive and safe environment provided by trained therapists is crucial for maximizing the therapeutic potential of MDMA and minimizing the risks associated with its use. The therapeutic applications of MDMA are diverse and far-reaching, with the potential to address a range of mental health conditions. The most well-established and researched application of MDMA is in the treatment of post-traumatic stress disorder (PTSD). PTSD is a debilitating condition that can develop after exposure to a traumatic event, such as combat, sexual assault, or natural disasters. It is characterized by symptoms like intrusive memories, avoidance of trauma-related stimuli, negative alterations in cognition and mood, and hyperarousal. Traditional treatments for PTSD, such as cognitive-behavioral therapy and medication, have limitations and are not effective for everyone. MDMA-assisted psychotherapy has emerged as a promising alternative for individuals with PTSD, particularly those who have not responded to conventional treatments. The unique properties of MDMA, such as reducing fear and increasing empathy, make it well-suited for treating the core symptoms of PTSD. During MDMA-assisted therapy sessions, patients are able to revisit and process traumatic memories in a safe and supportive environment. The drug reduces the fear and emotional numbing associated with these memories, allowing patients to engage with them in a more constructive way. They can access and express emotions that may have been suppressed or avoided, leading to a cathartic release and a new perspective on their experiences. The Multidisciplinary Association for Psychedelic Studies (MAPS) has been at the forefront of research on MDMA-assisted therapy for PTSD. Their clinical trials have yielded impressive results, with a significant proportion of participants experiencing long-lasting improvements in their symptoms. In fact, the results have been so promising that the FDA has granted MDMA-assisted therapy a Breakthrough Therapy designation for PTSD, accelerating its path to approval. A recent article in The New York Times highlighted the anticipation surrounding the FDA's potential approval of MDMA-assisted therapy for PTSD. The article emphasized the transformative potential of this treatment, which could provide relief for the millions of individuals suffering from PTSD worldwide. It also underscored the importance of continued research and responsible use of MDMA in therapeutic settings. While PTSD is currently the primary focus of MDMA therapy research, there is growing interest in exploring its potential for other mental health conditions. Preliminary studies suggest that MDMA could be beneficial for treating depression, anxiety, and social anxiety in autistic adults. Depression, characterized by persistent low mood, loss of interest, and feelings of hopelessness, is a widespread and debilitating mental health condition. Current treatments, such as antidepressant medications and psychotherapy, are not always effective, leaving many individuals struggling with ongoing symptoms. MDMA's ability to promote emotional openness, self-compassion, and insight could make it a valuable tool in the treatment of depression. Similarly, MDMA's prosocial effects and reduction of fear could be particularly useful for individuals with anxiety disorders, including social anxiety disorder. By reducing the emotional barriers that prevent individuals from engaging in social situations, MDMA could facilitate exposure therapy and help individuals develop more adaptive coping strategies. Autism spectrum disorder (ASD) is another area where MDMA therapy shows promise. Many individuals with ASD struggle with social interactions and communication, which can lead to anxiety and isolation. MDMA's ability to enhance empathy and reduce social fears could help autistic adults navigate social situations more effectively and form meaningful connections with others. As research continues to expand, it's likely that new therapeutic applications of MDMA will emerge. The unique properties of this drug, combined with the supportive environment of psychotherapy, hold significant potential for addressing a range of mental health challenges. The resurgence of interest in MDMA as a therapeutic tool has been driven by a growing body of clinical research. In recent years, several landmark clinical trials have provided compelling evidence for the efficacy and safety of MDMA-assisted therapy, particularly for the treatment of PTSD. The most notable clinical trials have been conducted by the Multidisciplinary Association for Psychedelic Studies (MAPS), a non-profit research and educational organization dedicated to the development of medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics. MAPS has been at the forefront of MDMA research for over three decades, working tirelessly to advance the scientific understanding and clini

MDMA (3,4-methylenedioxymethamphetamine), known commonly as Ecstasy or Molly, has transitioned from a popular recreational drug to a promising therapeutic tool. The unique psychoactive properties of MDMA, which enhance empathy and reduce fear, have made it a powerful aid in psychotherapy, particularly for treating severe psychological conditions like PTSD. This article delves into the historical context, mechanism of action, therapeutic applications, clinical trials, safety considerations, and future prospects of MDMA in therapeutic settings. MDMA has a fascinating history that spans over a century. It was first synthesized by the German pharmaceutical company Merck in 1912 as part of their research into blood-clotting medications. However, the psychoactive properties of MDMA remained unknown for decades. It wasn't until the 1970s that American chemist Alexander Shulgin re-synthesized MDMA in his lab. Shulgin, known for his pioneering work in psychedelic chemistry, recognized the unique effects of MDMA on the human psyche. Shulgin shared his findings with psychotherapist Leo Zeff, who saw the potential of MDMA as a therapeutic aid. Zeff introduced MDMA to the psychotherapy community, where it quickly gained popularity as a tool for facilitating emotional breakthroughs and enhancing the therapeutic alliance. Throughout the late 1970s and early 1980s, MDMA was used by a network of therapists who believed in its ability to catalyze healing. However, MDMA's rising popularity extended beyond therapeutic circles. It became a sought-after recreational drug, particularly in the rave and club scene. The increasing non-medical use of MDMA led to concerns about its potential for abuse and neurotoxicity. In 1985, the U.S. Drug Enforcement Administration (DEA) stepped in and classified MDMA as a Schedule I controlled substance. This classification placed severe restrictions on the legal use of MDMA, effectively halting its use in therapy and limiting research into its potential benefits. Despite the legal obstacles, a dedicated group of researchers and advocates continued to explore the therapeutic potential of MDMA. Organizations like the Multidisciplinary Association for Psychedelic Studies (MAPS) played a crucial role in advancing MDMA research, conducting clinical trials, and advocating for policy changes to facilitate its medical use. To understand how MDMA exerts its therapeutic effects, it's essential to examine its mechanism of action in the brain. MDMA primarily acts on three key neurotransmitter systems: serotonin, dopamine, and norepinephrine. When MDMA enters the brain, it causes a significant release of these neurotransmitters, leading to a cascade of psychological and physiological effects. Serotonin is perhaps the most important neurotransmitter involved in MDMA's action. MDMA causes a massive surge in serotonin levels, which is responsible for the drug's mood-elevating and prosocial effects. This increase in serotonin leads to feelings of euphoria, emotional warmth, and increased empathy. It allows individuals to connect with their emotions and with others in a profound way, which can be particularly beneficial in a therapeutic context. Dopamine, often associated with reward and motivation, is also affected by MDMA. The release of dopamine contributes to the pleasurable and energizing effects of the drug. It can enhance focus and engagement during therapy sessions, helping patients stay present and committed to the therapeutic process. Norepinephrine, a neurotransmitter involved in the body's stress response, is also increased by MDMA. This can lead to some of the physical effects of the drug, such as increased heart rate and blood pressure. However, the release of norepinephrine also plays a role in the emotional impact of MDMA. It can heighten emotional arousal and help individuals access and process difficult emotions. In addition to its effects on these neurotransmitters, MDMA has been shown to increase the release of oxytocin, often referred to as the "love hormone." Oxytocin is involved in social bonding, trust, and emotional regulation. The surge of oxytocin induced by MDMA can create a profound sense of connection and trust between the patient and therapist, fostering a strong therapeutic alliance. The combination of these neurochemical effects creates a unique psychological state characterized by reduced fear and defensiveness, increased empathy and emotional openness, and a heightened capacity for introspection and self-reflection. This state is particularly conducive to therapeutic work, allowing patients to access and process traumatic memories, emotions, and beliefs in a way that may not be possible under normal circumstances. It's important to note that the therapeutic effects of MDMA are not solely due to its pharmacological action. The drug is used as part of a carefully designed therapeutic protocol that includes preparatory sessions, MDMA-assisted sessions, and integrative follow-up sessions. The supportive and safe environment provided by trained therapists is crucial for maximizing the therapeutic potential of MDMA and minimizing the risks associated with its use. The therapeutic applications of MDMA are diverse and far-reaching, with the potential to address a range of mental health conditions. The most well-established and researched application of MDMA is in the treatment of post-traumatic stress disorder (PTSD). PTSD is a debilitating condition that can develop after exposure to a traumatic event, such as combat, sexual assault, or natural disasters. It is characterized by symptoms like intrusive memories, avoidance of trauma-related stimuli, negative alterations in cognition and mood, and hyperarousal. Traditional treatments for PTSD, such as cognitive-behavioral therapy and medication, have limitations and are not effective for everyone. MDMA-assisted psychotherapy has emerged as a promising alternative for individuals with PTSD, particularly those who have not responded to conventional treatments. The unique properties of MDMA, such as reducing fear and increasing empathy, make it well-suited for treating the core symptoms of PTSD. During MDMA-assisted therapy sessions, patients are able to revisit and process traumatic memories in a safe and supportive environment. The drug reduces the fear and emotional numbing associated with these memories, allowing patients to engage with them in a more constructive way. They can access and express emotions that may have been suppressed or avoided, leading to a cathartic release and a new perspective on their experiences. The Multidisciplinary Association for Psychedelic Studies (MAPS) has been at the forefront of research on MDMA-assisted therapy for PTSD. Their clinical trials have yielded impressive results, with a significant proportion of participants experiencing long-lasting improvements in their symptoms. In fact, the results have been so promising that the FDA has granted MDMA-assisted therapy a Breakthrough Therapy designation for PTSD, accelerating its path to approval. A recent article in The New York Times highlighted the anticipation surrounding the FDA's potential approval of MDMA-assisted therapy for PTSD. The article emphasized the transformative potential of this treatment, which could provide relief for the millions of individuals suffering from PTSD worldwide. It also underscored the importance of continued research and responsible use of MDMA in therapeutic settings. While PTSD is currently the primary focus of MDMA therapy research, there is growing interest in exploring its potential for other mental health conditions. Preliminary studies suggest that MDMA could be beneficial for treating depression, anxiety, and social anxiety in autistic adults. Depression, characterized by persistent low mood, loss of interest, and feelings of hopelessness, is a widespread and debilitating mental health condition. Current treatments, such as antidepressant medications and psychotherapy, are not always effective, leaving many individuals struggling with ongoing symptoms. MDMA's ability to promote emotional openness, self-compassion, and insight could make it a valuable tool in the treatment of depression. Similarly, MDMA's prosocial effects and reduction of fear could be particularly useful for individuals with anxiety disorders, including social anxiety disorder. By reducing the emotional barriers that prevent individuals from engaging in social situations, MDMA could facilitate exposure therapy and help individuals develop more adaptive coping strategies. Autism spectrum disorder (ASD) is another area where MDMA therapy shows promise. Many individuals with ASD struggle with social interactions and communication, which can lead to anxiety and isolation. MDMA's ability to enhance empathy and reduce social fears could help autistic adults navigate social situations more effectively and form meaningful connections with others. As research continues to expand, it's likely that new therapeutic applications of MDMA will emerge. The unique properties of this drug, combined with the supportive environment of psychotherapy, hold significant potential for addressing a range of mental health challenges. The resurgence of interest in MDMA as a therapeutic tool has been driven by a growing body of clinical research. In recent years, several landmark clinical trials have provided compelling evidence for the efficacy and safety of MDMA-assisted therapy, particularly for the treatment of PTSD. The most notable clinical trials have been conducted by the Multidisciplinary Association for Psychedelic Studies (MAPS), a non-profit research and educational organization dedicated to the development of medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics. MAPS has been at the forefront of MDMA research for over three decades, working tirelessly to advance the scientific understanding and clini

MDMA Therapy

برنامج ساعة لقلبك هو أحد أهم البرامج الإذاعية الفكاهية في تاريخ مصر، وقد ترك بصمة عميقة في وجدان المستمعين. بدأ البرنامج في الخمسينات واستمر حتى بداية الستينات، وحقق نجاحًا ساحقًا بفضل طاقم عمله المميز وسيناريوهاته المبتكرة.

Top Podcasts / Page 28305

Apparecchio alla morte

Algo de Magia

Fábrica de Sonidos

El Sampler

Un cafecito de Propiedad Intelectual

كن أنت | Bee you

Helden Podcast - Heldenreisen und Heldentaten

MILLIONAIRE SPIRIT - Aus dem Alltag einer Unternehmerfamilie

Botafogo PodCast

The Euro Step Brit Podcast

Hönspodden

Paathaka Loka - A Kannada True Crime Podcast

Dream DPC

べびぽんの『起きてたって、寝言。』

Økonomiske principper

The Sword Strider Saga

Cani, capirli per educarli

Sami's Bedtime Stories

La Liturgie des Heures

Parlons organisation, avec Sarah

Ehandelsnack

Hồ Biểu Chánh - Tiểu Thuyết Và Truyện Ngắn

عيش

נדלן משפחתי

cinema de akubi

Histórias pra adulto dormir

ひた農らじお

The Review Show

言語化.fm

MDMA Therapy

ساعة لقلبك

Ιστορίες Ουάου

Auch-Interessant BONUS

こんプロラジオ

Small Talk with Rino

Spiritual Talks

United States Real Estate Investor® News

Contrôle parental

Le futur de l'énergie

Irish Science Fiction

Shakespeare tükre

Into the Word

Begleitung ins innere Gebet

In Therapy with Jess

花 the fuck

بودكاست حياة - الموسم الثاني - بِقاع

Tous saints ! - Ces témoins de la foi racontés par Bénédicte Delelis

Everything Environment by Mongabay India

空。姐阿姨聊人生

10 Commandments